H.C. Wainwright maintained a positive stance on Arcturus Therapeutics (NASDAQ:ARCT) shares, reiterating a Buy rating and a price target of $63. Currently trading at $16.97, the stock has significant ...

U.S.-listed Coinbase (COIN) and MicroStrategy (MSTR) traded more than 5.9% lower in pre-market trading, while mining stocks ...

Stock markets around the fell as President Trump imposed tariffs on key trading partners, Canada, Mexico and China ...

Asian cryptocurrency stocks took a beating on Feb. 3 as Bitcoin fell as far as $91,163, its lowest level in over three weeks, ...

Tokyo stocks plunged on Monday as concerns over the impact of U.S. tariffs on the global economy led to a broad sell-off, ...

Japanese Shares: "Japanese stocks fell amid uncertainties about the global economic outlook, which includes worries that ...

Japan’s benchmark Nikkei 225 stock average lost more than 1,000 points temporarily Monday morning, with a wide range of ...

Descente Ltd. has delisted its shares for trading on the Prime Market of the Tokyo Stock Exchange, Inc. (TSE). The move was ...

Terra Drone Corporation, recognized as the No.1 Drone Service Provider in the world for 2024, has announced the ...

Stocks surrendered early gains and closed lower after the White House said President Donald Trump would impose promised ...

Wall Street pointed higher early Friday as more strong earnings results trickled in along with a closely-watched report from ...

Japanese Prime Minister Shigeru Ishiba will hold talks with OpenAI CEO Sam Altman and SoftBank Group CEO Masayoshi Son on ...